Origins of DNA methylation defects in Wilms tumors

Cancer Lett. 2019 Aug 10:457:119-128. doi: 10.1016/j.canlet.2019.05.013. Epub 2019 May 16.

Abstract

Wilms tumor is an embryonic renal cancer that typically presents in early childhood and accounts for 7% of all paediatric cancers. Different genetic alterations have been described in this malignancy, however, only a few of them are associated with a majority of Wilms tumors. Alterations in DNA methylation, in contrast, are frequent molecular defects observed in most cases of Wilms tumors. How these epimutations are established in this tumor is not yet completely clear. The recent identification of the molecular actors required for the epigenetic reprogramming during embryogenesis suggests novel possible mechanisms responsible for the DNA methylation defects in Wilms tumor. Here, we provide an overview of the DNA methylation alterations observed in this malignancy and discuss the distinct molecular mechanisms by which these epimutations can arise.

Keywords: Epigenetic mutations; Genomic imprinting; Nephroblastoma.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • DNA Methylation*
  • Epigenesis, Genetic*
  • Gene Expression Regulation, Neoplastic
  • Genes, Wilms Tumor*
  • Genetic Loci
  • Genetic Predisposition to Disease
  • Humans
  • Kidney Neoplasms / genetics*
  • Kidney Neoplasms / metabolism
  • Kidney Neoplasms / pathology
  • Phenotype
  • Signal Transduction
  • Wilms Tumor / genetics*
  • Wilms Tumor / metabolism
  • Wilms Tumor / pathology